Table 4 Association of microRNA expression and allelic imbalance.

From: An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation

  

ADC (n = 66)

SCC (n = 53)

Total (n = 119)

microRNA

Locus

Amplification

Deletion

Amplification

Deletion

Amplification

Deletion

miR-205

Chr1 q32.2

23/66 (34.8%)

4/66 (6.1%)

6/53 (11.3%)

9/53 (16.7%)

29/119 (24.4%)

13/119 (10.9%)

miR-296

Chr20 q13.32

No allelic imbalance

No allelic imbalance

miR-21

Chr17 q23.2

No allelic imbalance

No allelic imbalance

miR-23b

Chr9 q22.32

No allelic imbalance

No allelic imbalance

miR-126

Chr9 q34

4/66 (6.1%)

10/66 (15.2%)

7/53 (13.2%)

12/53 (22.6%)

11/119 (9.2%)

22/119 (18.5%)

miR-145

Chr5 q32

No allelic imbalance

No allelic imbalance

miR-150

Chr19 q13.33

8/66 (12.1%)

12/66 (18.2%)

2/53 (3.7%)

7/53 (13.2%)

10/119 (8.4%)

19/119 (16.0%)

miR-31

Chr9 p21.3

4/66 (6.1%)

8/66 (12.1%)

2/53 (3.7%)

12/53 (22.6%)

6/119 (5.0%)

20/119 (16.8%)

Back to article page